Tropism-modification strategies for targeted gene delivery using adenoviral vectors.
about
New viruses for cancer therapy: meeting clinical needsOncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic ApplicationsDevelopment of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based ConstructsA short perspective on gene therapy: Clinical experience on gene therapy of gliomablastoma multiformeCircumventing antivector immunity: potential use of nonhuman adenoviral vectorsOncolytic adenovirus-mediated therapy for prostate cancerGene delivery to adipose tissue using transcriptionally targeted rAAV8 vectorsDevelopment of a generic adenovirus delivery system based on structure-guided design of bispecific trimeric DARPin adaptersThyroid malignant neoplasm-associated biomarkers as targets for oncolytic virotherapyDevelopment of Adenoviral Delivery Systems to Target Hepatic Stellate Cells In VivoCell entry and trafficking of human adenovirus bound to blood factor X is determined by the fiber serotype and not hexon:heparan sulfate interactionA novel capsid-modified oncolytic recombinant adenovirus type 5 for tumor-targeting gene therapy by intravenous routeBarriers to inhaled gene therapy of obstructive lung diseases: A reviewAdenoviral vectors as novel vaccines for influenza.Development of a novel efficient method to construct an adenovirus library displaying random peptides on the fiber knob.Peptide-based technologies to alter adenoviral vector tropism: ways and means for systemic treatment of cancerOncolytic viruses: From bench to bedside with a focus on safety.Viruses in cancer treatment.Safety profiles and antitumor efficacy of oncolytic adenovirus coated with bioreducible polymer in the treatment of a CAR negative tumor modelMutation in fiber of adenovirus serotype 5 gene therapy vector decreases liver tropism.Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in miceAd5:Ad48 hexon hypervariable region substitutions lead to toxicity and increased inflammatory responses following intravenous deliveryRetargeted oncolytic adenovirus displaying a single variable domain of camelid heavy-chain-only antibody in a fiber protein.A Novel Vaccine Approach for Chagas Disease Using Rare Adenovirus Serotype 48 Vectors.Site-specific gene delivery to stented arteries using magnetically guided zinc oleate-based nanoparticles loaded with adenoviral vectorsEvaluation of CD46 re-targeted adenoviral vectors for clinical ovarian cancer intraperitoneal therapy.Pseudotyped αvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapies.An easy method for preparation of Cre-loxP regulated fluorescent adenoviral expression vectors and its application for direct reprogramming into hepatocytes.Human full-length coagulation factor X and a GLA domain-derived 40-mer polypeptide bind to different regions of the adenovirus serotype 5 hexon capsomer.Multiple roles of the coagulation protease cascade during virus infection.Manipulation of adenovirus interactions with host factors for gene therapy applications.Optimization and preclinical design of genetically engineered viruses for human oncolytic therapy.Novel gene delivery systemsAdenoviruses as gene/vaccine delivery vectors: promises and pitfalls.Assessment of Specificity of an Adenovirus Targeted to HER3/4.iRGD tumor-penetrating peptide-modified oncolytic adenovirus shows enhanced tumor transduction, intratumoral dissemination and antitumor efficacy.Biodistribution and inflammatory profiles of novel penton and hexon double-mutant serotype 5 adenoviruses.Getting genetic access to natural adenovirus genomes to explore vector diversity.Effect of Function-Enhanced Mesenchymal Stem Cells Infected With Decorin-Expressing Adenovirus on Hepatic Fibrosis.Exploration of New Sites in Adenovirus Hexon for Foreign Peptides Insertion.
P2860
Q24567699-EB028DD3-9D5D-4831-ABCD-7E38B214C6A8Q26776553-56663EA6-3130-4646-9707-BFF588B5724CQ26782083-13995982-6873-4C75-973F-5CEE69AB4677Q26849375-58F88FCD-0AEF-4476-9C16-D72882E945D3Q26995655-89AA8B69-4B4C-4319-825A-73B7A73B1C44Q27004796-D9F05267-9D31-466A-A404-FCFB774A1C60Q27318007-C15B4D50-168C-4726-8CB1-0B8578C6CD17Q27676519-6C01B11E-3003-4C95-9A5A-67B63096EBE0Q28071977-E713C038-8AD3-43AB-933F-1444678F4D7FQ28534124-7E0F27FA-DCA8-492F-A363-FAA1306F1CF0Q28744246-5243DE59-845F-4DB2-9C29-0AE61DAF4F35Q28817910-B402F417-0650-452D-8CA2-CAE758811C4AQ29248141-7EBAC3CD-BC67-438F-8C62-F7E27235E2E6Q30370445-599191CC-F91D-4D92-89DC-58CD87107050Q31146926-633DF366-05F1-40FB-AAE3-C08C3661E28FQ33584756-30DE771F-92B1-4F3D-BE41-2827B5F51AACQ34044071-C0C3BEDE-EABB-450A-AADC-F9613D1882CFQ34311097-39339B96-1261-400D-9684-CEEEA2521395Q34959758-EBAB3D8F-A0BF-4E95-806E-DB677100B0D7Q35017003-2CE0B73D-ADE9-4211-8AD2-7ED7796D53F3Q36291682-A5EB13B5-49D0-420F-8E9B-5A4CA84922F5Q36445557-B139B52D-51B4-4526-95DA-FAF50970D538Q36664240-36C12FCF-DD65-4030-AE35-BB0768AE7DCCQ36735672-4E5CC461-431F-41C5-81A4-7E755E66B138Q36860331-315809CC-85A2-4CDB-A730-2C69DF711B5CQ37100291-72D89C7F-39DB-4F8F-9355-C5639BA91939Q37317439-C75592E4-A1C2-4E13-8780-5270882DD0A4Q37714826-399832ED-2BFB-4923-8780-6FDFA5A7682EQ37719202-2BFB3CDF-D4D9-4C7D-8CE0-DD750AB08AE5Q37723466-80D96E96-E557-4F7B-9629-4DEA2F23BEEEQ37984486-72D5B0F8-E2A0-484D-B605-DCCE6B824A10Q38025696-5AB6B252-F2E0-4B5B-B287-A0ABF1CC0AB2Q38116870-EFB3AEB8-6DDA-4A54-9743-893328597A42Q38295771-166FD268-4957-4697-87C6-6A1705352F0FQ38645041-C4E3554D-FB49-4582-82BB-A921B50697EAQ38983280-441028DF-9784-4B90-A650-9C798AA6F1E9Q39342777-AC301416-F356-4BB4-9907-128908C7BFDFQ39437315-EAB480D8-1133-4486-A2CF-3237A3C7AE6FQ40629414-5E8D7C1F-6D34-4F20-82D6-33F6B889A7ABQ41165765-AB462902-426C-4CFF-9DFF-1AEAFFF0BF17
P2860
Tropism-modification strategies for targeted gene delivery using adenoviral vectors.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Tropism-modification strategies for targeted gene delivery using adenoviral vectors.
@en
type
label
Tropism-modification strategies for targeted gene delivery using adenoviral vectors.
@en
prefLabel
Tropism-modification strategies for targeted gene delivery using adenoviral vectors.
@en
P2093
P2860
P50
P356
P1433
P1476
Tropism-modification strategies for targeted gene delivery using adenoviral vectors.
@en
P2093
Andrew H Baker
Angela C Bradshaw
P2860
P304
P356
10.3390/V2102290
P577
2010-10-13T00:00:00Z